Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GSK

Recent news which mentions GSK

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
27 28 Next >
GSK's Meningitis Vaccine Candidate: Crushing Clinical Trials or Just Playing Catch-up with Bexsero and Menveo?
Tickers GSK
Tags News Briefs Biotech
From Benzinga
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
Tickers AZN AZNCF GSK SNY
Tags AZNCF Market News Benzinga
From Benzinga
GSK Trims Stake On Consumer Business Spin Off, Raises £804M
Tickers GSK HLN PFE
Tags Market News HLN Benzinga
From Benzinga
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer
Tickers GSK MRNA PFE
Tags Market News GSK MRNA
From Motley Fool
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
Tickers AZN BNTX GSK JNJ
Tags Biotech AZN MRNA
From Benzinga
A Shot of Success: GSK's Arexvy Wins FDA Approval, Pioneering RSV Prevention for Older Adults in Multi-Billion Dollar Market
Tickers GSK PFE
Tags Market News PFE Benzinga
From Benzinga
FDA approves GSK RSV vaccine
Tickers GSK SPX
Tags SPX GSK
From MarketWatch
KVUE Stock: Should You Buy Into the Kenvue IPO?
Tickers BAC GS GSK HLN
Tags GSK GS Today's Market
From InvestorPlace
Pharma Giant Pfizer To Start Selling Haleon Stake Within Months, CFO Says
Tickers GSK HLN PFE UL
Tags Guidance General News
From Benzinga
GSK Stock: A Value Trap or a Hidden Gem?
Tickers BLU GSK
Tags NYSE:GSK,NASDAQ:BLU BLU GSK
From InvestorPlace
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
Tickers BMY GSK LLY TNXP
Tags TNXP GSK Biotech
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ABBV APLS BAX CTLT
Tags CTLT APLS GSK
From Benzinga
3 Biotechs That Might Get Bought Out in 2023
Tickers AMLX AUPH BLU GSK
Tags Market News MRK AMLX
From Motley Fool
Was This Acquisition a Savvy Play by This Big Pharma Stock?
Tickers BLU GSK
Tags Recent Press Releases BLU GSK
From Motley Fool
GSK Clocks 10% Growth In Q1 Sales Excluding COVID-19 Products, Reaffirms Guidance
Tickers GSK
Tags Guidance General GSK
From Benzinga
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value
Tickers BHC GSK XENE
Tags Expert Ideas Market News BHC
From Benzinga
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
Tickers AMGN ARWR GSK TAK
Tags Market News GSK ARWR
From Motley Fool
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Tickers BAYRY GSK HLN INTC
Tags MBLY BAYRY JNJ
From Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
Tickers GSK MRK SNY TAK
Tags Government TKPHF General
From Benzinga
Why Shares of Bellus Health Skyrocketed This Week
Tickers BLU GSK MRK
Tags BLU Recent Press Releases Market News
From Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
Tickers BLU GSK MRK RXDX
Tags Recent Press Releases BLU RXDX
From Motley Fool
Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories
Tickers AAPL BABA BAC BK
Tags Aerospace & Defense JNJ GSK
From Benzinga
Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
Tickers BAC BBBY BK BLU
Tags JNJ FRC SCHW
From MarketWatch
Why Is Bellus Health (BLU) Stock Up 98% Today?
Tickers BLU GSK GSMG
Tags Market News GSMG Today's Market
From InvestorPlace
If King Dollar is wobbling, this asset is your best investment, says Citi
Tickers AAPL AGQ AMC BABA
Tags GS INFY SI00
From MarketWatch
GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
Tickers BLU GSK
Tags General M&A BLU
From Benzinga
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
Tickers BLU GSK
Tags BLU CA:BLU UK:GSK
From MarketWatch
This Favorable Sign Appears On GSK's Chart
Tickers GSK
Tags Benzinga Trading Ideas Markets
From Benzinga
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
Tickers GSK MRNA PFE
Tags Recent Press Releases PFE Market News
From Motley Fool
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
Tickers ADAP GSK RHHBY
Tags ADAP RHHBY Recent Press Releases
From Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.